+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anthracycline-induced cardiomyopathy



Anthracycline-induced cardiomyopathy



Postgraduate Medicine 120(4): 67-72



Anthracyclines are potent chemotherapeutic agents associated with 3 different forms of cardiomyopathy. Acute cardiomyopathy is seen within 3 months of drug exposure and may take the form of either a reversible myocarditis and pericarditis or an early-onset type and a late-onset type of chronic cardiomyopathy. Chronic anthracycline-induced cardiomyopathy is treated similarly to ischemic cardiomyopathies with beta-blockade and angiotensin-converting enzyme (ACE) inhibition. This review focuses on recent research regarding mechanisms of anthracycline-induced myocardial damage, the noninvasive imaging diagnosis of anthracycline-induced cardiomyopathy, and potential areas of future research regarding genetic screening and selecting individuals at increased risk, with consideration of prophylactic treatment with medications, specifically carvedilol and ACE inhibitors.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051563303

Download citation: RISBibTeXText

PMID: 19020367

DOI: 10.3810/pgm.2008.11.1940


Related references

Anthracycline antibiotics as cellular disruptors: insights into anthracycline-induced cardiomyopathy. Mount Sinai Journal of Medicine, New York 51(3): 246-253, 1984

An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy. Biomed Research International 2015: 465342, 2016

Anthracycline-induced cardiomyopathy. Postgraduate Medical Journal 75(883): 265-268, 1999

Anthracycline-induced cardiomyopathy. Presse Medicale 38(6): 987-994, 2009

Anthracycline-induced cardiomyopathy in rabbits. Physiological Research 49(3): 4P, 2000

Anthracycline-Induced Cardiomyopathy in Adults. Comprehensive Physiology 5(3): 1517-1540, 2016

Cardiomyopathy induced by anthracycline-derivates. Acta Paediatrica Scandinavica 73(3): 387-391, 1984

An anthracycline antibiotic-induced cardiomyopathy in rabbits. Laboratory Investigation; a Journal of Technical Methods and Pathology 30(3): 292-304, 1974

Anthracycline-induced cardiomyopathy and heart transplantation. European Journal of Medicine 1(5): 313, 1992

Management options: Anthracycline-induced cardiomyopathy. Postgraduate Medical Journal 75(883): 265-268, 1999

Anthracycline-induced cardiomyopathy in a dog treated with epirubicin. Canadian Veterinary Journal 56(6): 571-574, 2016

Anthracycline-induced cardiomyopathy: The search continues. Journal of Nuclear Cardiology 24(1): 265-267, 2015

Pharmacologic prevention of anthracycline-induced cardiomyopathy. Cardiology in Review 17(5): 243-252, 2009

Anthracycline-induced cardiomyopathy: secrets and lies. European Journal of Heart Failure 20(5): 907-909, 2018

123 I-MIBG imaging for detection of anthracycline-induced cardiomyopathy. Clinical Physiology and Functional Imaging 38(2): 176-185, 2017